4.09
-0.1(-2.39%)
Currency In USD
| Previous Close | 4.19 |
| Open | 4.18 |
| Day High | 4.23 |
| Day Low | 4.02 |
| 52-Week High | 7.05 |
| 52-Week Low | 2.03 |
| Volume | 92,685 |
| Average Volume | 147,150 |
| Market Cap | 214.18M |
| PE | -4.26 |
| EPS | -0.96 |
| Moving Average 50 Days | 3.86 |
| Moving Average 200 Days | 3.39 |
| Change | -0.1 |
If you invested $1000 in Sight Sciences, Inc. (SGHT) since IPO date, it would be worth $122.09 as of August 20, 2025 at a share price of $4.09. Whereas If you bought $1000 worth of Sight Sciences, Inc. (SGHT) shares 3 years ago, it would be worth $529.11 as of August 20, 2025 at a share price of $4.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease
GlobeNewswire Inc.
Jul 30, 2025 11:00 AM GMT
Cost-Utility Analysis published in the Expert Review of Pharmacoeconomics and Outcomes ResearchMENLO PARK, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company
Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease
GlobeNewswire Inc.
Jul 29, 2025 11:00 AM GMT
Mean signs and symptoms for participants in Stage 3 of the SAHARA trial remained statistically significantly better than study baseline at all time points measured up to 24 monthsMENLO PARK, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Sight Sciences,
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 8:05 PM GMT
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care